{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:45Z","timestamp":1788581565614,"version":"build-2803163510"},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"9","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08015"],"award-info":[{"award-number":["23K08015"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K11432"],"award-info":[{"award-number":["26K11432"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0639","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:09:55Z","timestamp":1780351795000},"page":"1061-1068","source":"Crossref","is-referenced-by-count":0,"title":["The clinical significance of <i>SIGLEC1<\/i> mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes"],"prefix":"10.1507","volume":"73","author":[{"given":"Mami","family":"Gamo-Kawasaki","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Kawai","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Takei","sequence":"additional","affiliation":[{"name":"Collaborative Research Center, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Collaborative Research Center, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototaka","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Takebayashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-689X","authenticated-orcid":false,"given":"Koshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bliddal S, Nielsen CH, Feldt-Rasmussen U (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res 6: 1776.","DOI":"10.12688\/f1000research.11535.1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, et al. (2020) Graves\u2019 disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab 34: 101387.","DOI":"10.1016\/j.beem.2020.101387"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29: 697\u2013725.","DOI":"10.1210\/er.2008-0015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Betterle C, Furmaniak J, Sabbadin C, Scaroni C, Presotto F (2023) Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest 46: 643\u2013665.","DOI":"10.1007\/s40618-022-01994-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, et al. (2006) The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 91: 1087\u20131092.","DOI":"10.1210\/jc.2005-1407"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Einarsdottir E, S\u00f6derstr\u00f6m I, L\u00f6fgren-Burstr\u00f6m A, Haraldsson S, Nilsson-Ardnor S, et al. (2003) The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto\u2019s thyroiditis and Graves\u2019 disease. Eur J Hum Genet 11: 81\u201384.","DOI":"10.1038\/sj.ejhg.5200903"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Valdes AM, Varney MD, Erlich HA, Noble JA (2013) Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetes. Diabetes Care 36: 2504\u20132507.","DOI":"10.2337\/dc12-2284"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, et al. (2005) Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90: 4904\u20134911.","DOI":"10.1210\/jc.2004-2236"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Li L, Liu S, Yu J (2020) Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective? Ther Adv Endocrinol Metab 11: 2042018820958329.","DOI":"10.1177\/2042018820958329"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Frommer L, Kahaly GJ (2021) Type 1 diabetes and autoimmune thyroid disease\u2014the genetic link. Front Endocrinol (Lausanne) 12: 618213.","DOI":"10.3389\/fendo.2021.618213"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 O\u2019Neill AS, van den Berg TK, Mullen GE (2013) Sialoadhesin\u2014a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138: 198\u2013207.","DOI":"10.1111\/imm.12042"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Xiong YS, Zhou YH, Rong GH, Wu WL, Liang Y, et al. (2009) Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease. Clin Biochem 42: 1057\u20131063.","DOI":"10.1016\/j.clinbiochem.2009.02.026"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Rose T, Szelinski F, Lisney A, Reiter K, Fleischer SJ, et al. (2016) SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sj\u00f6gren\u2019s syndrome. RMD Open 2: e000292.","DOI":"10.1136\/rmdopen-2016-000292"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Biesen R, Demir C, Barkhudarova F, Gr\u00fcn JR, Steinbrich-Z\u00f6llner M, et al. (2008) Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 58: 1136\u20131145.","DOI":"10.1002\/art.23404"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Vilcek J (2006) Fifty years of interferon research: aiming at a moving target. Immunity 25: 343\u2013348.","DOI":"10.1016\/j.immuni.2006.08.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zorn-Pauly L, von Stuckrad ASL, Klotsche J, Rose T, Kallinich T, et al. (2022) Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus. Rheumatology (Oxford) 61: 3396\u20133400.","DOI":"10.1093\/rheumatology\/keab875"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, et al. (2007) A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 56: 1010\u20131020.","DOI":"10.1002\/art.22382"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Rose T, Gr\u00fctzkau A, Hirseland H, Huscher D, D\u00e4hnrich C, et al. (2013) IFN\u03b1 and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis 72: 1639\u20131645.","DOI":"10.1136\/annrheumdis-2012-201586"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Mariette X, Gottenberg JE (2010) Pathogenesis of Sj\u00f6gren\u2019s syndrome and therapeutic consequences. Curr Opin Rheumatol 22: 471\u2013477.","DOI":"10.1097\/BOR.0b013e32833c36c5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Hashimoto K, Nishihara E, Matsumoto M, Matsumoto S, Nakajima Y, et al. (2018) Sialic acid-binding immunoglobulin-like lectin 1 as a novel predictive biomarker for relapse in Graves\u2019 disease: a multicenter study. Thyroid 28: 50\u201359.","DOI":"10.1089\/thy.2017.0244"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Wang Y, Jin Z, Sun J, Chen X, Xie P, et al. (2022) The role of activated monocyte IFN\/SIGLEC1 signalling in Graves\u2019 disease. J Endocrinol 255: 1\u20139.","DOI":"10.1530\/JOE-21-0453"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22 Ferreira RC, Guo H, Coulson RM, Smyth DJ, Pekalski ML, et al. (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63: 2538\u20132550.","DOI":"10.2337\/db13-1777"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Edgar L, Akbar N, Braithwaite AT, Krausgruber T, Gallart-Ayala H, et al. (2021) Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation 144: 961\u2013982.","DOI":"10.1161\/CIRCULATIONAHA.120.046464"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hu R, Xia CQ, Butfiloski E, Clare-Salzler M (2018) Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clin Immunol 195: 139\u2013148.","DOI":"10.1016\/j.clim.2018.06.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Rodrigues KB, Dufort MJ, Llibre A, Speake C, Rahman MJ, et al. (2020) Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes. Diabetologia 63: 1576\u20131587.","DOI":"10.1007\/s00125-020-05179-4"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ25-0639\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:38:19Z","timestamp":1788579499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ25-0639\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0639","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0639"}}